Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma

Joseph Tuscano, Mrinal Dutia, Karen Chee, Ann Brunson, Christine Reed-Pease, Mehrdad Abedi, Jeanna L Welborn, Robert T O'Donnell

Research output: Contribution to journalArticle

53 Scopus citations

Fingerprint Dive into the research topics of 'Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences